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History of Animal 
Contact, Italy
To the Editor: Streptococcus suis, 
a major swine pathogen worldwide, is 
emerging as a zoonotic agent capable 
of causing a variety of serious infec-
tions in swine as well as in persons 
exposed to pigs or to pork products. 
These infections include meningitis, 
septicemia, pneumonia, endocarditis, 
arthritis, and septic shock (1,2). De-
spite recent outbreaks among persons 
in China, S. suis disease in humans is 
a rare, probably underdiagnosed in-
fection that usually occurs as sporadic 
cases (1,2). Persons in close occupa-
tional or accidental contact with pigs 
or pork products and those who eat 
uncooked or undercooked pork may 
be at higher risk than others. How-
ever, most infected persons are likely 
healthy carriers, and S. suis is believed 
to induce overt disease (especially 
meningitis) in only some circumstanc-
es (2). We describe a case of S. suis 
meningitis in a 68-year-old man from 
Sardinia, Italy, who had no reported 
contact with swine, other animals, or 
any animal products; the patient also 
had cancer, which was discovered in-
cidentally during the workup.
In November 2007, the patient 
was hospitalized with a 48-hour his-
tory of fever, headache, nausea, and 
general malaise. Physical examina-
tion showed impaired consciousness, 
nuchal rigidity, and a temperature of 
39.5°C. Laboratory ﬁ  ndings  were 
20,700 leukocytes/mm3 with 92% 
neutrophils, glucose 95 mg/dL, and 
C-reactive protein 375 mg/L. Cere-
brospinal ﬂ  uid (CSF) analysis demon-
strated 240 leukocytes/μL with 80% 
polymorphonuclear cells, glucose 
24 mg/dL, and protein 277 mg/dL. 
A computed tomography scan of the 
head showed no abnormal ﬁ  ndings. 
Gram stain of CSF showed gram-pos-
itive cocci, mostly in pairs (Figure).
Empirical therapy consisted of 
intravenous ceftriaxone (2 g twice a 
day) and oral chloramphenicol (2 g 
once a day). On day 5, α-hemolytic 
streptococci were isolated from CSF 
on sheep blood agar and identiﬁ  ed as 
S. suis by using APIStrep (bioMérieux, 
Marcy l’Etoile, France). Serotyping, 
performed by slide agglutination with 
speciﬁ  c antiserum (Statens Serum In-
stitute, Copenhagen, Denmark), iden-
tiﬁ  ed the isolate as serotype 2.
Antimicrobial  drug  –susceptibility 
testing, performed according to guide-
lines of the Clinical and Laboratory 
Standards Institute (www.clsi.org), in-
dicated susceptibility to penicillin, cef-
triaxone, chloramphenicol, levoﬂ  oxa-
cin, and vancomycin and resistance to 
erythromycin (MIC >128 mg/L) and 
tetracycline (MIC 16 mg/L). Erythro-
mycin resistance was constitutive and 
was mediated by the erm(B) determi-
nant; tetracycline resistance was me-
diated by tet(W). Multilocus sequence 
typing (http://ssuis.mlst.net) assigned 
the  S. suis isolate to sequence type 
(ST) 1.
The patient, a retired welder, de-
nied any recent occupational or even 
occasional contact with swine or other 
animals and had no history of eating 
raw or undercooked pork. The pa-
tient’s condition improved; chloram-
phenicol was discontinued on day 10, 
but the 14-day course of ceftriaxone 
was completed. On day 6, the patient 
1946  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 12, December 2008LETTERS
became afebrile but had dizziness and 
deafness; a formal audiology evalua-
tion on day 9 showed severe bilateral 
sensorineural high-frequency hearing 
loss (–80 dB) that improved after a 
short course of dexamethasone. How-
ever, the patient was not discharged 
because of the lung mass found on 
initial chest radiograph. Computed 
tomography scan, bronchoscopy, and 
histopathologic ﬁ  ndings led to diagno-
sis of the mass as an advanced-stage 
squamous cell carcinoma.
The meningitis had common and 
uncommon features. The common 
features were hearing loss, a typical 
outcome of S. suis meningitis inde-
pendent of early antimicrobial drug 
administration (1,2); serotype 2, the 
most frequent and virulent serotype in 
swine and in humans (1,2); ST1, be-
longing to the ST1 complex, strongly 
associated with S. suis meningitis 
isolates (2,3); and erm(B)-mediated 
erythromycin resistance, widespread 
in this species (4). The uncommon 
features were tetracycline resistance 
mediated by tet(W), increasingly de-
tected in gram-positive and in gram-
negative bacteria (5) but never previ-
ously reported in S. suis or in other 
major streptococcal pathogens, where 
common determinants are tet(M) and 
tet(O); and lack of evidence for recent 
contact with swine, other animals, or 
swine (pork) products.
Two previous cases of human 
S. suis meningitis in Italy (6,7) and 
other recent cases from Europe (8,9) 
were related to occupational exposure. 
However, the patient reported here 
also had cancer, and malignancy has 
been indicated as a predisposing factor 
for the development of severe S. suis 
disease in humans (2). These ﬁ  ndings 
appear to be consistent with the re-
cent suggestion of new epidemiologic 
patterns of infection caused by this 
organism (2). S. suis may become an 
opportunistic pathogen in persons who 
are under stress or who have immuno-
deﬁ  ciency, and it has been increasingly 
isolated from mammalian species 
other than pigs, from birds, and from 
the environment. As also discussed 
in a recent survey (10), the possibil-
ity cannot be excluded that a patient 
with S. suis infection may be unaware 
or have no memory of previous expo-
sure to animals. Alternatively, because 
asymptomatic carriage of S. suis has 
been documented in humans (2) and is 
believed to contribute to its transmis-
sion (10), the possibility should also be 
considered that the infection may be a 
reactivation, possibly favored by ma-
lignancy, of latently colonizing S. suis.
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Equine Herpesvirus 
Type 9 in Giraffe 
with Encephalitis
To the Editor: Herpesviruses 
have been isolated from many mam-
mals. Herpesvirus infection in natural 
hosts is often mild and is usually fol-
lowed by a latent infection; however, 
cross-species herpesvirus infections 
cause severe and fatal diseases. Equine 
herpesvirus (EHV)–1 causes abortion, 
respiratory disease, and, occasionally, 
neurologic disorders in horses. EHV-1 
infection is usually limited to equine 
species, although it has also been found 
in other species (1), in which it causes 
fatal encephalitis. Recent sequence 
analyses suggested that the equine 
herpesviruses isolated in the United 
States from onagers (Equus hemio-
nus), Grevy’s zebras (E. grevyi), and 
Thomson’s gazelles (Gazella thomso-
ni) are a subtype or variant of EHV-1 
(2). With respect to epizootiology, the 
nonequine animals affected by EHV-1 
or EHV-1–related virus were kept in 
enclosures adjacent to those of zebra 
species (Grevy’s or Burchell’s).
Another EHV-related virus was 
isolated from 2 Thomson’s gazelles 
that had encephalitis and were kept 
with zebras (3). The virus was lat-
er found to be a new type of EHV, 
EHV-9, although it was serologically 
cross-reactive with EHV-1 (3). Re-
cently, neutralizing antibodies against 
EHV-9 were found among Burchell’s 
zebras in the Serengeti ecosystem (4).
A herpesvirus was recently iso-
lated from a reticulated giraffe (Gi-
raffa camelopardalis reticulate) with 
neurologic symptoms; the giraffe 
was from a zoo in the United States 
(5). Nonsuppurative encephalitis was 
found by histopathologic examination 
of the giraffe brain. Several Burchell’s 
zebras that were apparently healthy 
and later determined to be seropositive 
for EHV-1 were housed in the same 
pen as the giraffe. The isolated virus 
was identiﬁ  ed by PCR and a monoclo-
nal antibody assay as EHV-1 (5). In 
the present study, we analyzed 4 gene 
sequences of the giraffe herpesvirus 
to show its relatedness to EHV-1 and 
EHV-9.
We ampliﬁ  ed portions of 4 genes 
from giraffe herpesvirus DNA by PCR. 
The DNA polymerase catalytic sub-
unit (open reading frame [ORF] 30) 
gene was ampliﬁ  ed by using herpes-
virus universal primers (6). The genes 
for glycoprotein B (gB) (ORF33), 
glycoprotein 2 (gp2) (ORF71), and 
glycoprotein D (gD) (ORF72) were 
ampliﬁ  ed by using primers speciﬁ  c for 
EHV-9. The ORF33 primers were gB-F 
(5′-GGCACAATAGTCCTAGCATG
TCTGTTGCTG-3′) and gB-R (5′-
AAATATCCTCAGGGCCGGAAC
TGGAAAGTG-3′). The ORF71 prim-
ers were gp2-F (5′-CCCCGTTGATG
AGTTTTGCGTAGAGGTCTA-3′) 
and gp2-R (5 ′-GCCACCACTGGTTG
TAAAGGCCAAGAGATA-3′). 
The ORF72 primers were gD-F (5′-
TTTACAACCACTGGTGGCGT
GTGTGCAGAA-3′) and gD-R (5′-
TATCTCCAAACCGCGAAGCTT-
TAAGGCCGT-3′). The ampliﬁ  ed 
products were used as templates for 
direct sequencing (Dragon Genom-
ics, Mie, Japan). The sequences were 
edited with Phred, Phrap, and Consed 
(www.phrap.org/phredphrapconsed.
html), and the phylogenic trees were 
constructed with PHYLIP (2,7). Ac-
cession numbers of the sequences 
(submitted to the DNA Data Bank of 
Japan) are given in the Figure.
We used PCR to amplify a part of 
the gB gene of the giraffe herpesvirus, 
and we used EHV-1 speciﬁ  c primers 
for sequencing. However, we could 
not obtain amplicons (data not shown). 
Therefore, the more conserved gene, 
ORF30, was sequenced. The sequence 
of the 1,066-bp segment of the giraffe 
herpesvirus ORF30 gene was 99.5% 
identical to EHV-9 and 94.6% identi-
cal to EHV-1, which indicates that the 
giraffe herpesvirus was most closely 
related to EHV-9. Therefore, EHV-9 
ORF33–speciﬁ  c primers were used to 
amplify the corresponding region of 
the giraffe herpesvirus. The sequence 
of the giraffe herpesvirus ORF33 was 
98.8% identical to EHV-9 and 95.9% 
identical to EHV-1. Also, the sequence 
of the other envelope glycoproteins 
(ORF71 and ORF72) of the giraffe her-
pesvirus were 99.8% and 99.6% iden-
tical to EHV-9 and 91.6% and 96.3% 
identical to EHV-1. A phylogenic tree 
of maximum likelihood showed that 
EHV-9 and the giraffe virus formed a 
genetic group that was apparently dis-
tinguished from other genetic groups 
of EHV (Figure).
Herpesviruses have caused clini-
cal disease in zoo animals, including a 
case of EHV-9 infection in Thomson’s 
gazelles (3) and a recently described 
endotheliotropic betaherpesvirus in-
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